Revision as of 01:20, 3 October 2011 editMeodipt (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers35,772 editsNo edit summary← Previous edit | Revision as of 01:21, 3 October 2011 edit undoMeodipt (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers35,772 editsNo edit summaryNext edit → | ||
Line 31: | Line 31: | ||
==See also== | ==See also== | ||
* ] | |||
* ] | * ] | ||
* ] | * ] |
Revision as of 01:21, 3 October 2011
Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.269 g/mol g·mol |
3D model (JSmol) | |
SMILES
|
3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world.
See also
References
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |